News 12's Elizabeth Hashagen was joined by Dr. Thomas McGinn to talk about COVID-19 vaccines for children as young as 6 months.
The Centers for Disease Control and Prevention gave final approval for COVID-19 vaccines for young children.
Asked to compare them at a news briefing, Dr. Peter Marks, who heads the Food and Drug Administration's vaccine division, said that Moderna's vaccine might trigger the immune response "slightly more rapidly," while Pfizer's might "bring a greater response after the third dose."
McGinn talked about the vaccine's safety and if there is a difference between the two.